Table 3.

Summary of TEAEs

TEAE, n (%)	Any grade (N=78)	Grade ≥3 (N=78)
Any	76 (97.4)	41 (52.6)
Immune-related TEAE	18 (23.1)	2 (2.6)
TEAEs, regardless of attribution, that led to discontinuation	9 (11.5)	8 (10.3)
Most common TEAEs (>10%), regardless of attribution
Fatigue	21 (26.9)	2 (2.6)
Rash	13 (16.7)	1 (1.3)
Anemia	12 (15.4)	5 (6.4)
Constipation	11 (14.1)	—
Diarrhea	11 (14.1)	—
Nausea	10 (12.8)	—
Hypercalcemia	9 (11.5)	1 (1.3)
Hyponatremia	9 (11.5)	2 (2.6)
Localized infection	9 (11.5)	1 (1.3)
Peripheral edema	9 (11.5)	—
Arthralgia	8 (10.3)	—
Cellulitis	8 (10.3)	1 (1.3)
Cough	8 (10.3)	—
Insomnia	8 (10.3)	—
Pruritus	8 (10.3)	—

TEAE, treatment-emergent adverse event.